Biohaven Ltd
BHVN
Market Cap$1.63B
Close$
$0.69
95.7% downside
Current Fair Value
95.7% downsideOvervalued by 95.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.63 Billion |
|---|---|
| Enterprise Value | $1.78 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-9.28 |
| Beta | 3.5 |
| Outstanding Shares | 102,372,820 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.05 |
|---|---|
| PEG | 5.4 |
| Price to Sales | - |
| Price to Book Ratio | 15.87 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.22 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 2.35 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Biohaven Pharmaceutical Holding Company Ltd
CEO: Vlad Coric